Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL

Giovanni Riva, Mario Luppi, Ivana Lagreca, Patrizia Barozzi, Chiara Quadrelli, Daniela Vallerini, Eleonora Zanetti, Sabrina Basso, Fabio Forghieri, Monica Morselli, Monica Maccaferri, Ambra Paolini, Valeria Fantuzzi, Andrea Messerotti, Rossana Maffei, Ilaria Iacobucci, Giovanni Martinelli, Roberto Marasca, Franco Narni, Patrizia ComoliLeonardo Potenza

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)299-302
Number of pages4
JournalBritish Journal of Haematology
Volume164
Issue number2
DOIs
Publication statusPublished - Jan 2014

Keywords

  • ALL
  • BCR-ABL1
  • Imatinib
  • MRD
  • T cells

ASJC Scopus subject areas

  • Hematology

Cite this

Riva, G., Luppi, M., Lagreca, I., Barozzi, P., Quadrelli, C., Vallerini, D., Zanetti, E., Basso, S., Forghieri, F., Morselli, M., Maccaferri, M., Paolini, A., Fantuzzi, V., Messerotti, A., Maffei, R., Iacobucci, I., Martinelli, G., Marasca, R., Narni, F., ... Potenza, L. (2014). Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL. British Journal of Haematology, 164(2), 299-302. https://doi.org/10.1111/bjh.12612